Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 10, 2026
Catalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount
View original at finance.yahoo.comCatalyst Pharmaceuticals: Exceptional Fundamentals Trading at 20-33% Discount This article first appeared on GuruFocus. Introduction: At $24.50, what you're really getting with Catalyst Pharmaceuticals Inc…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
Hetero litigation expected to conclude sometime in 2026
80% confidenceFIRDAPSE patent protection extends through February 2035
80% confidenceEstimated 3,000-4,000 US patients with Lambert-Eaton Myasthenic Syndrome
80% confidenceThere are approximately 15,000 patients in the US with Duchenne Muscular Dystrophy
80% confidenceCurrent R&D spending is about 5-8% of revenue
80% confidence